Knowledge, attitude and practices towards pharmacovigilance among health care professionals in a teaching and general hospital of South India

Zainab Ghazala; Prakash Kalshetty; Shrenik Vardhamane

doi:10.18203/2319-2003.ijbcp20190091

Authors

Zainab Ghazala Department of Pharmacology, Khaja Bandanawaz Institute of Medical Sciences, Kalaburagi, Karnataka, India
Prakash Kalshetty Department of Pharmacology, Khaja Bandanawaz Institute of Medical Sciences, Kalaburagi, Karnataka, India
Shrenik Vardhamane Department of Pharmacology, Khaja Bandanawaz Institute of Medical Sciences, Kalaburagi, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20190091

Keywords:

Adverse drug reaction, Attitude, Healthcare professionals, Knowledge, Practice, Pharmacovigilance, Underreporting

Abstract

Background: Pharmacovigilance is the science and activities relating to detection, monitoring, assessment, understanding and prevention of adverse effects or any other drug related problem from any pharmaceutical products. The core purpose of pharmacovigilance is to enhance patient care and generate the evidence based information on safety of medicines. The objective of present study was to evaluate the knowledge, attitude and practices of the healthcare professionals about pharmacovigilance and to assess the reasons for underreporting of ADRs.

Methods: A cross-sectional study was conducted by administering KAP questionnaire to the healthcare professionals. There were 22 multiple choice questions. Ten related to knowledge, 5 related to attitude, and 6 related to practice. One question was asked to determine the reasons for underreporting of ADRs. The performance in each category was graded as good, average and poor if the number of participants giving correct/positive responses were >70%, 50-69%, <50% respectively. Question no 22 was assessed independently to find out reasons for underreporting of ADRs. Data was compiled and analyzed by descriptive statistics, Chi-square and ANOVA test.

Results: The response rate in this study was 62.5%. The study included professors (11%), associate professors (6%), assistant professors (20%), postgraduates (26%) and interns (37%). That there was statistically very highly significant difference of mean score of knowledge, attitude and practice among health care professionals (P<0.001). The performance score with respect to attitude of health care professionals towards pharmacovigilance was good as compared to knowledge which was average followed by practice which showed poor performance (72.5% >51.6% >36.8%) (p <0.001).

Conclusions: Awareness campaigns, CMEs, workshops on pharmacovigilance should be conducted regularly such that good knowledge about pharmacovigilance can be imparted which can be moulded into good practice.

Metrics

Metrics Loading ...

References

The World Health Organization. Safety of medicines: A guide to detecting and reporting adverse drug reactions. Geneva; 2002. Available at: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/ (Accessed on 2018 sept 02).

Makary MA, Michael D. Medical error-the third leading cause of death in the US. BMJ. 2016;353:i2139.

Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136-47.

Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol. 2008;65:210-6.

Adithan C. National pharmacovigilance programme. Indian J Pharmacol. 2005;37:34.

Pharmacovigilance programme of India 2010. CDSCO, Ministry of Health and Family Welfare, Government of India; 2010, Nov. Available at: http://www.cdsco.nic.in/pharmacovigilance. Accessed on 2018 sept 02.

Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 1996;42:423‑9.

Shirodkar SN. India become seventh largest contributor to WHO‑UMC’s drug safety data base. Available at: http://www.pharmabiz.com. Accessed on 2018 Apr 02.

Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration. J Gen Intern Med. 2003;18:57-60.

Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med. 2005;165:1363-9.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitude and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Nat Sci Biol Med. 2013;4:191-6.

Muraraiah S, Rajarathna K, Sreedhar D, Basavalingu D, Jayanthi CR. A questionnaire study to assess the knowledge, attitude and practice of Pharmacovigilance in a paediatric tertiary care centre. J Chem Pharm Res. 2011;3:416-22.

Hardeep, Bajaj JK, Kumar R. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India. J Clin Diagn Res. 2013;7:97-9.

Rehan HS, Chopra D, Sah RK, Mishra R. Adverse drug reactions: Trends in a tertiary care hospital. Curr Drug Saf. 2012;7:384-8.

Rehan HS, Sah RK, Chopra D. Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital. Indian J Pharmacol. 2012;44:699-703.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions among the resident doctors. J Pharm Sci Res. 2011;3:1064-9.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2:129-36.

Hasford J, Goettler M, Munter KH, Muller-Oerlinghausen. Physician’s knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2000;55:945-50.

Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res. 1997;35:85-8.

Vora MB, Barvaliya M. Knowledge, attitude, and practices towards Pharmacovigilance and adverse drug reactions in healthcare professionals of tertiary care hospital, Bhavnagar. Int J pharm Sci Res. 2014;5(11):820-6.

Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, et al. Awareness and attitudes of healthcare professionals in Wuhan, china to the reporting adverse drug reactions. Chin Med J Engl. 2004;117:856-61.

Radhakrishnan R, Vidyasagar S, Verma DM. An educational intervention to assess knowledge attitude practice of pharmacovigilance among healthcare professionals in an Indian Tertiary Care Teaching Hospital. Int J pharmtech Res. 2011;3:678-92.

Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: A systematic review. Drug Saf. 2009;32:19-31.

Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48:623-7.